A carregar...
Interruption of OX40L signaling prevents costimulation blockade–resistant allograft rejection
The potential of costimulation blockade to serve as a novel transplant immunosuppression strategy has been explored for over 20 years, culminating in the recent clinical approval of belatacept for renal transplant patients. Despite improving long-term graft function and survival compared with calcin...
Na minha lista:
| Publicado no: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5333968/ https://ncbi.nlm.nih.gov/pubmed/28289708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90317 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|